Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.2869
H.R.2869: Increasing Access to Biosimilars Act of 2021
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced April 28, 2021
- Latest Major Action April 29, 2021
- See the two similar bills introduced in other congresses.
Bill Sponsor
Bill Version
- Introduced in House - April 28, 2021
Bill Summary
Increasing Access to Biosimilars Act of 2021 This bill requires the Centers for Medicare & Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
April 29, 2021 |
Referred to the Subcommittee on Health.
|
April 28, 2021 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
April 28, 2021 |
Referred to the Subcommittee on Health.
|
April 28, 2021 |
Introduced in the House by Tony Cárdenas (D-Calif.) |